FIRST EXTENSION - GRANTED
granted
on 12 Sep 2024
Last Applicant/ Owned by
75 Hayden Avenue
Lexington
MA
02421
Serial Number
90531584 filed on 17th Feb 2021
Registration Number
N/A
Correspondent Address
Bridget H. Labutta
Bridget H. Labutta Panitch Schwarze Belisario & Nadel LLP
Two Commerce Square
Philadelphia, PA 19103
United States
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
GALXC
Research and development of pharmaceutical products; research and development of oligonucleotide drug delivery platforms for use in the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections Biologic preparations for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Research and development of pharmaceutical products; research and development of oligonucleotide drug delivery platforms for use in the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Biologic preparations for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases and viral infections; drug delivery agents consisting of a biological compound in the form of a molecular complex that acts as a platform that facilitates delivery of ribonucleic acid RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies; oligonucleotide compounds for use in the targeted delivery of RNA interference (RNAi) therapy; oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents intravenously or subcutaneously for use in targeted pharmaceutical therapies for a wide range of medical purposes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [040]
Treatment & Processing of Materials Services
Custom manufacture of oligonucleotides
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 90531584
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.05.15 -
Four or more triangles
26.05.16 -
Triangles touching or intersecting
26.05.21 -
Triangles that are completely or partially shaded
27.03.01 -
Geometric figures forming letters or numerals, including punctuation
Legal History
| Status Date | Action Taken |
|---|---|
| 12th Sep 2024 | SOU EXTENSION 1 FILED |
| 12th Sep 2024 | SOU EXTENSION 1 GRANTED |
| 12th Sep 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 12th Sep 2024 | SOU TEAS EXTENSION RECEIVED |
| 12th Mar 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 16th Jan 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 16th Jan 2024 | PUBLISHED FOR OPPOSITION |
| 27th Dec 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 13th Dec 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 10th Nov 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |